Healthcare Finance Staff
WellPoint is taking a tough stance to try to combat prescription drug abuse and fraud activities that bubble to the surface through predictive analytics and other data runs of its members and their providers and pharmacies.
McKesson Corp. is settling allegations of drug pricing inflation with Virginia Medicaid, in one of the largest such recoveries for a state.
Three weeks after the disastrous launch of its health insurance marketplace, the Obama administration has vowed to redouble its efforts to fix its many glitches, promising a 'tech surge' to iron out its problems and improve the customer experience.
I first posed the question "Could Mobile Health Become Addictive?" on August 20. Since then I've done more thinking, and I'm warming to the concept.
Many small businesses find the services offered by Affordable Care Act's SHOP exchanges attractive, but they're also interested in self-funding, a potential threat to the critical mass needed for HIXs to thrive.
The first insurer to report third quarter financials, UnitedHealth Group posted net quarterly earnings of $1.57 billion, a 1 percent year-over-year increase, with its Optum business contributing nearly 25 percent of profits.
Optum, part of UnitedHealth Group, and Dignity Health, one of the country's largest healthcare systems, have formed a revenue cycle management company, Optum360, that combines Dignity's revenue cycle management infrastructure and network scale with Optum's technology, analytics and broad client base of providers and health plans.
The term "value-based" insurance might strike average consumers as a bit odd: Shouldn't all insurance be value-based?
Community health centers will pay a steep price for states' decisions not to expand Medicaid under the federal health law.
The chief architect of the Genetic Information Nondiscrimination Act is asking the Equal Employment Opportunity Commission to investigate the use of genetic data in wellness programs and offer compliance guidance -- while large employers are hoping for more flexibility in tying incentives to genetic screening.